Biogen (BIIB) RSI Live Chart
Biogen (BIIB) is trading around $248.88. Its daily RSI is 60.99, which is neutral, and its weekly RSI is 70.77 (overbought). The table below shows the live RSI on every timeframe.
Biogen RSI by timeframe
| Timeframe | RSI (14) | Signal |
|---|---|---|
| 30m | 41.16 | Neutral |
| 1h | 44.67 | Neutral |
| 1d | 60.99 | Neutral |
| 1w | 70.77 | Overbought |
| 1mo | 66.65 | Neutral |
Live, updates every few minutes. RSI period 14.
Biogen at a glance
- 1 week
- −1.36%
- 1 month
- +13.16%
- 3 months
- +19.34%
- 1 year
- +66.46%
- 52-week high
- $258.78
- 52-week low
- $147.47
- Market cap
- $36.79B#277 in the S&P 500
- In the S&P 500 since
- 2003
Biogen (BIIB) is an S&P 500 company in the Health Care sector, classified under Biotechnology and headquartered in Cambridge, Massachusetts. Founded in 1978, it has been in the index since 2003. By market cap it is the 277th largest company in the S&P 500 and the 35th largest of 60 in Health Care.
Over the past year BIIB is up 66.5%, while the S&P 500 (SPY) is up 10.6%. It trades 3.8% below its 52-week high of $258.78 and 68.8% above its 52-week low of $147.47.
What the BIIB RSI tells you
The Relative Strength Index (RSI) measures the speed and size of recent price moves on a scale from 0 to 100. It is one of the most widely used momentum indicators in stock trading.
A reading at or below 30 is considered oversold: selling may be overextended and a bounce more likely. A reading at or above 70 is overbought: buying may be stretched and a pullback more likely. Between 30 and 70 is neutral. Signals are strongest when several timeframes agree, which is why the table above shows Biogen on all of them at once.
RSI is a guide, not a guarantee. A stock can stay oversold or overbought for a long time in a strong trend. Traders usually combine it with divergences, volume and structure, all of which you can check on the live chart.